Mira Pharmaceuticals MIRA Cash Flow Statement (2022-2025)

NASDAQ MIRA
$0.65 +0.01 (+1.25%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Mira Pharmaceuticals Quarterly Cash Flow Statement

Periods 15 quarters
Latest Dec 2025

Mira Pharmaceuticals reported cash from operations of -$1.17M and free cash flow of -$1.17M for the quarter ended Dec 2025, up 35.0% year over year. This cash flow statement covers 15 quarters of results from Jun 2022 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income -2.42M-1.81M-1.35M-1.34M-1.27M-3.59M-5.79M-1.72M-1.69M-2.04M-2.40M-1.78M-1.54M-1.14M-5.94M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges 0.44M
Share-based CompensationStock Comp. 0.15M0.15M0.15M0.74M1.45M0.21M0.50M0.60M0.27M0.55M0.87M0.53M0.40M4.51M
Gains from Investment SecuritiesGains Investment 0.18M-0.21M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp. 0.35M0.17M0.18M-0.45M0.12M-0.24M0.10M0.15M-0.09M0.03M-0.62M0.19M-0.21M0.05M
Change in Other Operating AssetsOther Assets Change 0.00M0.06M-0.02M0.16M0.05M-0.07M-0.08M-0.02M-0.03M0.10M-0.06M-0.04M-0.03M
Other Working Capital ChangesOther WC Changes 0.00M-0.06M0.02M-0.16M-0.05M0.07M0.08M0.02M0.03M-0.10M0.06M0.04M0.03M
Cash from OperationsCash from Ops. -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.63M-0.80M-1.10M-1.17M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance 1.05M
Long-Term Debt RepaymentsLT Debt Repayment 0.05M1.01M
Non-Current Debt -0.05M0.04M
Short-Term Debt issuancesST Debt Issuance 0.09M
Current Debt 0.09M
Net Debt Issuances and RepaymentsNet Debt Issuance -0.05M0.09M0.04M
Change in Capital Stock
Common Stock IssuedStock Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Net Shares Issued and RepurchasedNet Shares Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Net Equity Issued and RepurchasedNet Equity Issued 0.90M0.29M-0.40M3.23M-0.72M0.00M0.35M3.12M4.43M
Other financing activitiesOther financing 0.00M-0.05M-0.16M0.35M-0.02M0.01M0.05M-0.11M-0.16M
Cash from Financing ActivitiesCash from Financing 0.68M1.14M0.73M0.68M7.60M-0.23M-0.02M0.16M3.16M0.49M0.00M0.32M3.01M4.84M
Additional items
Change in Cash -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.63M-0.48M1.91M3.71M
Ending Cash Balance 0.83M0.19M0.35M0.00M0.02M5.87M4.60M3.53M2.82M4.14M2.83M1.21M0.73M2.64M6.35M
Free Cash FlowFCF -1.31M-0.98M-1.08M-0.66M-1.76M-1.04M-1.05M-0.86M-1.84M-1.81M-1.63M-0.80M-1.10M-1.17M
Net Cash FlowNCF -0.64M0.16M-0.35M0.02M5.84M-1.27M-1.07M-0.70M1.32M-1.31M-1.63M-0.48M1.91M3.67M

Mira Pharmaceuticals Cash Flow Statement API

Pull Mira Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=MIRA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY